Fulgent Genetics (FLGT) - Stock Price & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US3596641098
Fulgent Genetics, Inc. and its subsidiaries offer a wide range of clinical diagnostic and therapeutic solutions both in the United States and internationally, catering to physicians and patients. Their services encompass molecular and genetic testing, anatomic pathology tests like gastrointestinal, dermatopathology, urologic pathology, and oncology tests. They also provide next-generation sequencer services covering hereditary cancer, cardiovascular genetics, reproductive health, and neurodegenerative genetics.
Moreover, Fulgent Genetics focuses on therapeutic development by creating drug candidates to treat various cancers. They employ a unique nanoencapsulation and targeted therapy platform aimed at improving the effectiveness and safety profiles of cancer medications. The company also manages a picture genetics platform featuring exclusive gene probes, advanced data analytical tools, and laboratory information management systems to help individuals discover health indicators in their DNA.
Their clientele includes insurance companies, hospitals, medical institutions, laboratories, government entities, payors, municipalities, corporations, and individuals seeking their services. Initially known as Fulgent Diagnostics, the company rebranded as Fulgent Genetics in August 2016, having been established in 2011 with its headquarters situated in Temple City, California. For more information, visit their website: https://www.fulgentgenetics.com
Drawdown (Underwater) Chart
FLGT Stock Overview
Market Cap in USD | 613m |
Sector | Healthcare |
Industry | Diagnostics & Research |
GiC SubIndustry | Health Care Services |
TER | 0.00% |
IPO / Inception | 2016-09-29 |
FLGT Stock Ratings
Growth 5y | 1.76 |
Fundamental | -51.9 |
Dividend | - |
Rel. Performance vs Sector | -4.09 |
Analysts | 3.33/5 |
Fair Price Momentum | 18.52 USD |
Fair Price DCF | 3.88 USD |
FLGT Dividends
Yield 12m | 0.00% |
Yield on Cost 5y | 0.00% |
Dividends CAGR 5y | 0.00% |
Payout Consistency | 0.0% |
FLGT Growth Ratios
Growth 12m | -25.53% |
Growth Correlation 12m | -72% |
Growth Correlation 3m | -82% |
CAGR 5y | 26.07% |
Sharpe Ratio 12m | -0.73 |
Alpha vs SP500 12m | -58.13 |
Beta vs SP500 5y weekly | 1.29 |
ValueRay RSI | 70.06 |
Volatility GJR Garch 1y | 38.30% |
Price / SMA 50 | -2.88% |
Price / SMA 200 | -21.83% |
Current Volume | 164k |
Average Volume 20d | 163.3k |
External Links for FLGT Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X (Twitter) • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of May 03, 2024, the stock is trading at USD 21.24 with a total of 164,024 shares traded.
Over the past week, the price has changed by +6.04%, over one month by -0.14%, over three months by -13.83% and over the past year by -26.93%.
According to ValueRays Forecast Model, FLGT Fulgent Genetics will be worth about 20.8 in May 2025. The stock is currently trading at 21.24. This means that the stock has a potential downside of -1.98%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 26.7 | 25.6 |
Analysts Target Price | 36.5 | 71.8 |
ValueRay Target Price | 20.8 | -1.98 |